Schedule 13G ownership disclosure

Arcturus Therapeutics Holdings Inc

Common Stock · CUSIP: 03969T109

Event date: 2025-03-31

Filing-level shares
2,104,537
Percent of class
7.8%
  • BlackRock, Inc.

    Shares: 2,104,537 · Class: 7.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-25-001467
Form type
SCHEDULE 13G/A
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Apr 23, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub